GLUT1DS1: Clinical Trials

3 trials for GLUT1DS1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1

Follow GLUT1DS1: new trials by email Literature Review of GLUT1DS1 trials Research Report on GLUT1DS1

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome
L-fucose, Placebo - Glut1 Deficiency, GLUT1DS1
Phase 2RecruitingOregon Health and Science University162026-05-052026-05-13
Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D
Triheptanoin - GLUT1DS1
Phase 2CompletedUniversity of Texas Southwestern Medical Center102018-06-052024-01-17
Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)
Triheptanoin - GLUT1DS1, Epilepsy
Phase 2CompletedUniversity of Texas Southwestern Medical Center452018-04-182025-08-07

Narrower conditions

Glut1 Deficiency Syndrome (2)  ·  Epilepsy (1)  ·  Glucose Metabolism Disorders (1)  ·  Glycogen Storage Disease Id (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

triheptanoin (2)  ·  Fucose (1)

Sponsors

University of Texas Southwestern Medical Center (2)  ·  Oregon Health and Science University (1)

Countries

United States (3)

Top investigators

Juan Pascual, M.D. (1)  ·  Juan Pascual, MD (1)  ·  Rodrigo T. Starosta, MD, PhD (1)

Results publications

PMID 37268656

NIH funding

R01NS094257 (2)